Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 19, 2026 04:37 ET | Source: Zoomex

Moving Beyond HODL: ZOOMEX Launches Global "Pizza Week" Campaign Honoring Bitcoin’s First Real-World Trade

VICTORIA, Seychelles, May 19, 2026 (GLOBE NEWSWIRE) -- On the cusp of the global 16th anniversary of Bitcoin Pizza Day, ZOOMEX, a leading global digital asset exchange, today officially announced...
May 19, 2026 04:34 ET | Source: Research and Markets

Immunology Collaboration and Licensing Agreements Benchmark Report 2026: Access to 864 Deals, Delivering a Clear and Evidence-based View of How Partnerships are Designed, Negotiated, and Executed

Dublin, May 19, 2026 (GLOBE NEWSWIRE) -- The "Immunology Collaboration and Licensing Deals 2018-2026" report has been added to ResearchAndMarkets.com's offering.The definitive benchmark for...
May 19, 2026 04:30 ET | Source: Hesai Group

Hesai Group Reports First Quarter 2026 Unaudited Financial Results

Quarterly net revenues were RMB680.6 million (US$98.7 million)1 Quarterly lidar shipments were 471,723 units Quarterly net income was RMB18.3 million (US$2.7 million) SHANGHAI, China, May 19, 2026...
May 19, 2026 04:24 ET | Source: Research and Markets

Genitourinary Collaboration and Licensing Agreements Benchmark Report 2026: Access to Structured Analysis of 316 Deals Across Development Pathways, Therapeutic Approaches, and Commercial Strategies

Dublin, May 19, 2026 (GLOBE NEWSWIRE) -- The "Genitourinary Collaboration and Licensing Deals 2016-2026" report has been added to ResearchAndMarkets.com's offering.The definitive benchmark for...
May 19, 2026 04:12 ET | Source: Research and Markets

Gastrointestinal Collaboration and Licensing Agreements Benchmark Report 2026: Access to Structured Analysis of 432 Deals Signed Since 2016 - Finance, Indications, Modalities, Stages of Development

Dublin, May 19, 2026 (GLOBE NEWSWIRE) -- The "Gastrointestinal Collaboration and Licensing Deals 2016-2026" report has been added to ResearchAndMarkets.com's offering.The definitive benchmark for...
May 19, 2026 04:10 ET | Source: Research and Markets

Central Nervous System Collaboration and Licensing Agreements Benchmark Report 2026: Structured Analysis of 900+ Deals Signed Since 2020 - Financial Terms, Upfronts, Milestones, and Royalties

Dublin, May 19, 2026 (GLOBE NEWSWIRE) -- The "Central Nervous System Collaboration and Licensing Deals 2020-2026" report has been added to ResearchAndMarkets.com's offering.The definitive benchmark...
May 19, 2026 04:05 ET | Source: Research and Markets

Gynecology Collaboration and Licensing Agreements Benchmark Report 2026: Structured Analysis of 157 Deals, Delivering an Evidence-based View of How Partnerships are Designed, Negotiated, and Executed

Dublin, May 19, 2026 (GLOBE NEWSWIRE) -- The "Gynecology Collaboration and Licensing Deals 2016-2026" report has been added to ResearchAndMarkets.com's offering.The definitive benchmark for...
May 19, 2026 04:04 ET | Source: Research and Markets

Cardiovascular Collaboration and Licensing Agreements Benchmark Report 2026: Access to 650+ Deals Signed Since 2016 - Financial Terms, Upfronts, Milestones, and Royalties

Dublin, May 19, 2026 (GLOBE NEWSWIRE) -- The "Cardiovascular Collaboration and Licensing Deals 2016-2026" report has been added to ResearchAndMarkets.com's offering. This report provides a...
May 19, 2026 04:00 ET | Source: Amphiform

Amphiform Raises $5.5M Led by General Catalyst and Main Object to Solve Energy Bottlenecks for Data Centres, Space and Defence

Oxford-based deep tech startup is building atomically engineered fuel cells: 85% cheaper and 30x more power-dense, running on renewable liquid fuels.
May 19, 2026 04:00 ET | Source: Adrenomed AG

AdrenoMed Highlights Need for Personalized Therapies in Septic Shock Amid New Sepsis Guidelines and U.S. Policy Initiative

Hennigsdorf / Berlin (Germany), May 19, 2026 (GLOBE NEWSWIRE) -- Press Release AdrenoMed Highlights Need for Personalized Therapies in Septic Shock Amid New Sepsis Guidelines and U.S. Policy...